- €1.64bn
- €5.05bn
- €2.71bn
- 21
- 80
- 30
- 36
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,110 | 3,056 | 3,030 | 3,013 | 2,712 |
Cost of Revenue | |||||
Gross Profit | 720 | 660 | 701 | 744 | 505 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,698 | 3,383 | 2,723 | 2,632 | 3,188 |
Operating Profit | 412 | -327 | 307 | 381 | -476 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 272 | -469 | 276 | 493 | -623 |
Provision for Income Taxes | |||||
Net Income After Taxes | 236 | -524 | 262 | 425 | -509 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 234 | -308 | 212 | 327 | -473 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 234 | -308 | 212 | 327 | -473 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 14.6 | -15.5 | 11.8 | 16.6 | -21.4 |
Dividends per Share |